Showing results (41-50 of 1,474) with videos related to
Sort By:
Pageof 148
Archives of General Psychiatry|August 2, 2003
Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study GroupL A Adler, J Rotrosen, R Edson, et al.The American Journal of Psychiatry|June 1, 1979
Variable attenuation of amphetamine effects by lithiumB Angrist, S GershonNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 1993
A placebo-controlled trial of L-dopa/carbidopa in early cocaine abstinenceR Wolfsohn, M Sanfilipo, B AngristClinical Neuropharmacology|June 8, 2001
Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidolB Angrist, M Sanfilipo, A WolkinThe Journal of Pharmacy and Pharmacology|December 1, 1984
Murine lymphocytes lack clearly defined receptors for muscarinic and dopaminergic ligandsD E Wazer, J RotrosenThe American Journal of Psychiatry|March 1, 1996
Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptomsA Wolkin, M Sanfilipo, E Duncan, et al.British Journal of Pharmacology|May 1, 1975
Effects of acute cocaine treatment on the turnover of 5-hydroxytryptamine in the rat brainE Friedman, S Gershon, J RotrosenPsychopharmacology Communications|January 1, 1975
The search for the dopamine receptor: tribulationsJ Rotrosen, E Friedman, S GershonBiological Psychiatry|September 1, 1994
Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatologyA Wolkin, M Sanfilipo, B Angrist, et al.Psychopharmacologia|November 21, 1975
Clinical studies with dopamine-receptor stimulantsB Angrist, H Thompson, B Shopsin, et al.Pageof 148